Open Nav

Please submit your session questions in advance at

David Atkins



Dr Atkins is the CEO of Congenica, a leading provider of clinical decision support software used for interpreting genome data from patients with rare diseases. Congenica is a Cambridge based spinout from The Sanger Institute. David has 25 years’ experience as a global leader in a broad range of diagnostics, medical devices and healthcare businesses such as Johnson & Johnson, Danaher and Synevo. David has a PhD from University of East Anglia, UK and MBA from Columbia University, USA

This speaker's sessions: